Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.500
+0.200 (4.65%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $879.65 million as of April 1, 2026. Its market cap has increased by 41.54% in one year.
Market Cap
879.65M
Enterprise Value
792.37M
1-Year Change
41.54%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $879.65M, an increase of 1,751.90%. That is a compound annual growth rate of 19.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 879.70M | -4.91% |
| Dec 31, 2025 | 925.10M | 49.31% |
| Dec 31, 2024 | 619.60M | 47.81% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 874.67M |
| Aktis Oncology | 868.72M |
| Xencor | 832.39M |
| Phathom Pharmaceuticals | 829.75M |
| Fortrea Holdings | 829.35M |
| UroGen Pharma | 827.60M |
| MapLight Therapeutics | 823.69M |
| Cullinan Therapeutics | 812.26M |